OXFORD IMMUNOTEC GLOBAL LIMITEDActive
Key figures
Like most small UK companies, OXFORD IMMUNOTEC GLOBAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2023Balance sheet structure
Filed accounts2023
| 2023 | |
|---|---|
| Cash at bank and in hand | 706 |
| Total assets | 144,098 |
| Total liabilities | — |
| Net assets / total equity | 144,070 |
| Average number of employees | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2023The principal activity of the Company is that of a holding company on behalf of the Revvity (UK) Holdings Limited group of companies.
As described in the company's latest filed accounts.
Summary: OXFORD IMMUNOTEC GLOBAL LIMITED
Company
OXFORD IMMUNOTEC GLOBAL LIMITED is a private limited company registered with Companies House under company number 08654254. It was incorporated on 16 Aug 2013. Its status is active. The registered office is in Abingdon (OX14). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200).
Accounts
The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files full accounts. Net assets were £144,070. Cash at bank and in hand was £706. The company had an average of 0 employees.
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 28 Aug 2027.